Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E infected in acute C57BL6J (B6) mouse HAT model assessed as day of parasitemia relapse at 5 mg/kg, po qd administered for 5 days in presence of deoxycoformycin
Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E infected in acute C57BL6J (B6) mouse HAT model assessed as day of parasitemia relapse at 5 mg/kg, po qd administered for 5 days
Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E infected in acute C57BL6J (B6) mouse HAT model assessed as day of parasitemia relapse at 1 mg/kg, po bid administered for 5 days
Efflux ratio of apparent permeability across apical to basolateral side over basolateral to apical side in human Caco2 cells at 10 uM by LC-MS/MS analysis
Trypanocidal activity against bloodstream stage of Trypanosoma brucei brucei AnTat1.1E after 72 hrs by WST-1 assay in presence of adenosine kinase inhibitor ABT702